RYAH and Bazelet Enter Into MOU for 5-Year Medical Device Distribution Strategy for the RYAH Smart Inhaler in Israel
\”RYAH Group Secures Medical Device Certification for RYAH Smart Inhaler and Software\”
\”RYAH Group Secures Medical Device Certification for RYAH Smart Inhaler and Software\”
Since the 1970s, researchers have been investigating motivation in relation to cannabis use. Interestingly, while the stereotype about the unmotivated stoner persists to this day, most research finds little basis for this societal assumption. A new study seems to confirm further that cannabis consumers are just as motivated as non-users. But, as with many areas …
Cannabis’ Effect on Motivation Isn’t Straightforward Read More »
Since the early days of the HIV/AIDS epidemic, LGBTQ activists have fought for patient access to medical cannabis. In the 1980s and ‘90s, this community pushed for legal access, established compassion clubs, and eventually set the wheels in motion for the widespread legalization we see today. Long before the development of more modern medical interventions, …
New Studies Supporting Cannabis use By Patients with HIV/AIDS Read More »
In the world of cannabis research, the landscape is about to dramatically change for US-based scientists. Researchers will soon have access to flower and other cannabis products that actually represent what consumers and patients are using in the real world. With more than 50 years of study limited by the quality and variety of federally …
Cannabis Research in the US Is About to Change — for the Better Read More »
By some estimates, upwards of 90 percent of patients with an advanced cancer diagnosis suffer from chronic pain. Cancer-related pain can stem from the progression of cancer itself or from the various surgeries, treatments, and procedures deployed to combat it. While opioids are the most convenient option, increasingly patients are asking their oncologist about cannabis …
Cannabis for Cancer Pain: Patient Preferred with Growing Scientific Support Read More »
The cannabis industry seems to hold many assumptions about the female patient. The stereotype of the female patient is clear after a single Google: they stick with CBD-rich and low potency strains, they are more interested in the wellness side of the spectrum than the medicinal side, and they steer clear of smokables. These assumptions …